Συντάκτης: Pegky Dokou

ROME, August 10. /TASS/. Antibodies to coronavirus after receiving a second dose of the Russian Sputnik V vaccine were developed by 99% of the participants of a joint study by San Marino’s government and Italy’s Lazzaro Spallanzani National Institute for Infectious Diseases, representative of San Marino’s Institute for Social Security Franco Cavalli told TASS. “The study conducted jointly with the Lazzaro Spallanzani Institute is directed at researching the vaccine’s efficacy. In San Marino, the studies so far have been focused on measuring the level of antibodies 21 days after introducing the first dose and then 21 days after injecting the…

Διαβάστε περισσότερα